Korean J Ophthalmol.  2009 Mar;23(1):13-16. 10.3341/kjo.2009.23.1.13.

Intravitreal Triamcinolone Acetonide Injection at the Time of Pars Plana Vitrectomy for Retained Lens Material

• Kim NR
• Yoon JH
• Kang SM
• Chin HS

• KMID: 1115645
• DOI: http://doi.org/10.3341/kjo.2009.23.1.13

Abstract

PURPOSE: To report the experiences at our institute of pars plana vitrectomy (PPV) in combination with intravitreal triamcinolone acetonide (IVTA) injection in patients with retained lens material after cataract surgery.
METHODS
The medical records of patients who underwent PPV between January 2005 and December 2006 after complicated cataract surgery in which lens material was dropped into the vitreous cavity were reviewed retrospectively.
RESULTS
Five eyes of five patients were treated by vitrectomy and removal of the dislocated lens material and were administered an adjuvant intravitreal injection of 4 mg triamcinolone acetonide at the end of surgery. IVTA administration induced a rapid improvement in vision within six weeks postoperatively. Final visual acuity was 20/32 or better in all patients. Inflammatory cystoid macular edema (CME) that existed preoperatively was promptly improved after IVTA. Intraocular pressure increased transiently in one patient. No procedure-related complications were observed.
CONCLUSIONS
PPV with additional IVTA was successfully performed in five eyes with retained lens material and resulted in a marked resolution of vitreous inflammation, an improvement in CME and rapid visual recovery. The authors recommend that IVTA administration should be investigated more thoroughly as an adjunct during the management of retained lens material.

Keyword

Cataract; Cystoid macular edema; Dropped nucleus; Retained lens material; Triamcinolone acetonide

MeSH Terms

Aged
Cataract Extraction/adverse effects
Device Removal/*methods
Female
Follow-Up Studies
Glucocorticoids/*administration & dosage
Humans
Injections
Intraoperative Care/methods
Lens Subluxation/pathology/*surgery
Lenses, Intraocular/*adverse effects
Macular Edema/etiology/pathology/*surgery
Male
Middle Aged
Reoperation
Retrospective Studies
Time Factors
Tomography, Optical Coherence
Treatment Outcome
Triamcinolone Acetonide/*administration & dosage
Visual Acuity
Vitrectomy/*methods
Vitreous Body

Reference

1. Gilliland GD, Hutton WL, Fuller DG. Retained intravitreal lens fragments after cataract surgery. Ophthalmology. 1992. 99:1263–1267. discussion 1268-9.

2. Margherio RR, Margherio AR, Pendergast SD, et al. Vitrectomy for retained lensfragments after phacoemulsification. Ophthalmology. 1997. 104:1426–1432.

3. Borne MJ, Tasman W, Regillo C, et al. Ocutomes of vitrectomy for retained lens fragments. Ophthalmology. 1996. 103:971–976.

4. Merani R, Hunyor AP, Playfair TJ, et al. Pars plana vitrectomy for the management of retained lens material after cataract surgery. Am J Ophthalmol. 2007. 144:364–370.

5. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema. Am J Ophthalmol. 2003. 136:384–386.

6. Degenring RF, Jonas JB. Intravitreal injection of triamcinolone acetonide as treatment for chronic uveitis. Br J Ophthalmol. 2003. 87:361.

7. Cohen SM, Davis A, Cukrowski C. Cystoid macular edema after pars plana vitrectomy for retained lens fragments. J Cataract Refract Surg. 2006. 32:1521–1526.

8. Arbisser LB, Charles S, Howcroft M, Werner L. Management of vitreous loss and dropped nucleus during cataract surgery. Ophthalmol Clin North Am. 2006. 19:495–506.

9. Okhravi N, Lightman SL, Towler HM. Assessment of visual outcome after cataract surgery in patients with uveitis. Ophthalmology. 1999. 106:710–722.

10. Jampol LM. Pharmacologic therapy of aphakic and pseudophakic cystoid macular edema. 1985 update. Ophthalmology. 1985. 92:807–810.

11. Chin HS, Park TS, Moon YS, Oh JH. Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes. Retina. 2005. 25:556–560.